RecruitingPhase 2Phase 3NCT03804931

Fecal Microbiota Transplantation for Ulcerative Colitis

Efficacy and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis


Sponsor

Guangzhou First People's Hospital

Enrollment

120 participants

Start Date

Jan 20, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. Fecal microbiota transplantation has been used for several disease,but the efficacy of ulcerative colitis(UC) by fecal microbiota transplantation needs to be further explored.The investigators propose to determine the efficiency and safety of FMT in patients with ulcerative colitis(UC).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Active, moderate to severe severity (Mayo score more than 6)
  • Safety using history of 5-ASA
  • Able to undergo endoscopy examination

Exclusion Criteria4

  • Antibiotic using in 7 days
  • High risk of toxic megacolon
  • Colon cancer or neoplasia in pathophysiology
  • Other severe diseases (eg: cardiovascular, respiratory, gastroenteral and kidney diseases)

Interventions

PROCEDUREFecal microbiota transplantation

200 mL of prepared fecal microbiota suspension from healthy donors' fresh feces was injected into the intestine

PROCEDUREInfusion of Saline

Infusion of Saline

DRUG5-Aminosalicylic acid(5-ASA) and/or Prednisone

Mesalazine and/or Prednisone


Locations(1)

Guangzhou First People's Hospital

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03804931


Related Trials